Medasys | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
24,108.00
23,720.00
20,943.00
22,081.00
23,395.00
Cost of Goods Sold (COGS) incl. D&A
17,209.00
17,172.00
16,028.00
16,346.00
17,443.00
Gross Income
6,899.00
6,548.00
4,915.00
5,735.00
5,952.00
SG&A Expense
5,087.00
4,464.00
4,532.00
7,846.00
4,924.00
EBIT
1,287.00
-
383.00
-
1,429.00
Unusual Expense
300.00
-
150.00
1,549.00
291.00
Non Operating Income/Expense
382.00
260.00
7.00
72.00
86.00
Interest Expense
245.00
346.00
364.00
612.00
575.00
Pretax Income
1,132.00
1,353.00
904.00
4,813.00
2,381.00
Income Tax
41.00
1.00
1.00
4.00
111.00
Consolidated Net Income
1,091.00
1,352.00
903.00
4,817.00
2,270.00
Net Income
1,091.00
1,352.00
903.00
4,817.00
2,270.00
Net Income After Extraordinaries
1,091.00
1,352.00
903.00
4,817.00
2,270.00
Net Income Available to Common
1,091.00
1,352.00
903.00
4,817.00
2,270.00
EPS (Basic)
0.04
0.05
0.02
0.13
0.06
Basic Shares Outstanding
26,741.80
27,089.60
38,561.30
38,390.80
39,436.40
EPS (Diluted)
0.04
0.05
0.02
0.13
0.06
Diluted Shares Outstanding
28,746.70
28,379.40
38,561.30
38,390.80
39,436.40
EBITDA
3,981.00
3,832.00
2,221.00
519.00
2,157.00
Other Operating Expense
525.00
717.00
766.00
613.00
2,457.00
Non-Operating Interest Income
8.00
72.00
-
-
-
About Medasys
View Profile
